Programmed Cell Death in Diabetic Kidney Disease: Mechanisms and Therapeutic Targeting

Shanshan Tang1, Yuting Sun2, Wenjie Sun3,4

  • 1College of Traditional Chinese Medicine, Changchun University of Chinese Medicine, Changchun, People's Republic of China.

PubMed

Insights

Diabetic kidney disease (DKD) pathogenesis involves various programmed cell death (PCD) types, including apoptosis, autophagy, and pyroptosis. Understanding these PCD pathways is crucial for developing effective DKD therapies.

Area of Science:

  • Nephrology
  • Molecular Biology
  • Pathology

Background:

  • Diabetic kidney disease (DKD) presents a growing global health challenge with high mortality.
  • Programmed cell death (PCD) significantly influences DKD pathogenesis, acting in both homeostatic and pathological capacities.

Purpose of the Study:

  • To review and synthesize current knowledge on the role of diverse PCD pathways in DKD.
  • To explore the potential of PCD-targeted therapies for DKD treatment.

Main Methods:

  • Literature review synthesizing evidence on apoptosis, autophagy, pyroptosis, ferroptosis, necroptosis, and parthanatos in DKD.
  • Analysis of gene-regulated signaling pathways involved in PCD-mediated DKD progression.

Main Results:

  • Multiple PCD types, including apoptosis, autophagy, pyroptosis, and ferroptosis, are implicated in DKD progression.
  • Emerging evidence suggests complex interactions and crosstalk between different PCD pathways in DKD.
  • Recently identified PCD modes like necroptosis and parthanatos require further investigation in the context of DKD.

Conclusions:

  • Dissecting the multifaceted roles of PCD in DKD is essential for a deeper mechanistic understanding.
  • Targeting PCD pathways holds promise for developing novel therapeutic strategies for DKD.
  • Addressing current research limitations, such as unclear PCD interactions and translational gaps, is critical for clinical advancement.

Related Concept Videos

Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.2K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
3.9K
Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
9.4K
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
565
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
868
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
8.1K